Aldeyra Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Aldeyra Therapeutics Inc prices initial public offering of 1,500,000 shares of common stock
Aldeyra Therapeutics Inc:Announces pricing of its initial public offering of 1,500,000 shares of its common stock at a price to the public of $8.00 per share.Aldeyra expects gross proceeds from the offering to be $12,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses.Aldeyra has granted the underwriters a 45-day option to purchase up to 225,000 additional shares of common stock to cover over-allotments, if any.The shares are expected to begin trading on the NASDAQ Capital Market under the symbol "ALDX" on May 2.The offering is expected to close on May 7, 2014.Aegis Capital Corp. is acting as the sole book-running manager for the offering.
Latest Developments for Aldeyra Therapeutics Inc
Latest Key Developments in Biotechnology
- Share this
- Digg this